| 10000-8 | R wave duration in lead AVR |
| 10001-6 | R wave duration in lead I |
| 10002-4 | R wave duration in lead II |
| 10003-2 | R wave duration in lead III |
| 100030-6 | Axis I: Temporal aspects score |
| 100031-4 | Axis II: Spatial aspects score |
| 100032-2 | Axis III: Drug taking behavior score |
| 100033-0 | Axis IV: Utilization of the health care system score |
| 10004-0 | R wave duration in lead V1 |
| 10005-7 | R wave duration in lead V2 |
| 10006-5 | R wave duration in lead V3 |
| 100067-8 | Eye Image magnification |
| 10007-3 | R wave duration in lead V4 |
| 100070-2 | Right cornea Cell density |
| 100071-0 | Left cornea Cell density |
| 100072-8 | Right cornea Coefficient of variation |
| 100073-6 | Left cornea Coefficient of variation |
| 100074-4 | Right cornea Hexagonality |
| 100075-1 | Left cornea Hexagonality |
| 100076-9 | Right cornea Endothelial cells counted |
| 100077-7 | Left cornea Endothelial cells counted |
| 100078-5 | Right cornea Endothelial cell area.min |
| 100079-3 | Left cornea Endothelial cell area.min |
| 10008-1 | R wave duration in lead V5 |
| 100080-1 | Right cornea Endothelial cell area.max |
| 100081-9 | Left cornea Endothelial cell area.max |
| 100082-7 | Right cornea Endothelial cell area.mean |
| 100083-5 | Left cornea Endothelial cell area.mean |
| 100084-3 | Right cornea Cell area.standard deviation |
| 100085-0 | Left cornea Cell area.standard deviation |
| 10009-9 | R wave duration in lead V6 |
| 100091-8 | Trypanosoma cruzi Ab (immunoassay) |
| 10010-7 | R' wave amplitude in lead AVF |
| 100108-0 | Leishmania sp IgG Ab (immunoassay) |
| 10011-5 | R' wave amplitude in lead AVL |
| 10012-3 | R' wave amplitude in lead AVR |
| 100124-7 | Chlamydophila pneumoniae IgA Ab (immunoassay) |
| 10013-1 | R' wave amplitude in lead I |
| 10014-9 | R' wave amplitude in lead II |
| 10015-6 | R' wave amplitude in lead III |
| 100150-2 | 6(R+S)-oxo-propylpiperidine-2-carboxylate |
| 100151-0 | 6-oxo-piperidine-2-carboxylate |
| 100152-8 | 6-oxo-piperidine-2-carboxylate/Creatinine (Urine) |
| 100153-6 | 6(R+S)-oxo-propylpiperidine-2-carboxylate/Creatinine (Urine) |
| 100158-5 | Microalbumin collected for unspecified duration (Urine) |
| 10016-4 | R' wave amplitude in lead V1 |
| 100165-0 | Knee range of motion |
| 10017-2 | R' wave amplitude in lead V2 |
| 10018-0 | R' wave amplitude in lead V3 |
| 10019-8 | R' wave amplitude in lead V4 |
| 100196-5 | Pre-op total score |
| 100198-1 | Pre-op objective knee indicators score |
| 100199-9 | Pre-op symptoms score |
| 10020-6 | R' wave amplitude in lead V5 |
| 100200-5 | Pre-op patient expectations score |
| 100201-3 | Pre-op functional activities score |
| 100202-1 | Pre-op discretionary knee activities score |
| 100207-0 | Post-op total score |
| 100208-8 | Post-op objective knee indicators score |
| 100209-6 | Post-op symptoms score |
| 10021-4 | R' wave amplitude in lead V6 |
| 100210-4 | Post-op patient expectations score |
| 100211-2 | Post-op functional activities score |
| 100212-0 | Post-op discretionary knee activities score |
| 10022-2 | R' wave duration in lead AVF |
| 10023-0 | R' wave duration in lead AVL |
| 10024-8 | R' wave duration in lead AVR |
| 10025-5 | R' wave duration in lead I |
| 100255-9 | Total score |
| 10026-3 | R' wave duration in lead II |
| 10027-1 | R' wave duration in lead III |
| 100274-0 | Observing score |
| 100275-7 | Describing score |
| 100276-5 | Acting with awareness score |
| 100277-3 | Nonjudging score |
| 100278-1 | Nonreactivity score |
| 100279-9 | Total score |
| 10028-9 | R' wave duration in lead V1 |
| 100281-5 | D Ab |
| 100288-0 | Absence of deformity score |
| 10029-7 | R' wave duration in lead V2 |
| 100290-6 | Range of motion score |
| 100291-4 | Total score |
| 100292-2 | Pre-op patient satisfaction score |
| 100298-9 | Repetition count |
| 100299-7 | Post-op patient satisfaction score |
| 10030-5 | R' wave duration in lead V3 |
| 100300-3 | End time Unspecified body region |
| 100301-1 | Start time Unspecified body region |
| 100304-5 | Flights climbed Reporting Period |
| 10031-3 | R' wave duration in lead V4 |
| 10032-1 | R' wave duration in lead V5 |
| 10033-9 | R' wave duration in lead V6 |
| 10034-7 | S wave amplitude in lead AVF |
| 100341-7 | Rubella virus IgG Ab index and CSF |
| 100346-6 | Clotting time (Blood, thromboelastography.rotational.extrinsic coagulation system activated.platelets inhibited) |
| 100347-4 | Clot formation (Blood, thromboelastography.rotational.extrinsic coagulation system activated.platelets inhibited) |
| 100348-2 | Model for end-stage liver disease sodium score |
| 10035-4 | S wave amplitude in lead AVL |
| 100350-8 | Sesamum indicum 1 IgE Ab |